Defining the role of palliative radiotherapy in bone metastasis from primary liver cancer: An analysis of survival and treatment efficacy

Tumori

Volumn 97, Issue 5, 2011, Pages 609-613

  Habermehl, Daniel ^a   Haase, Kristina ^a   Rieken, Stefan ^a   Debus, Jürgen ^a   Combs, Stephanie E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bone metastasis; Cholangiocarcinoma; Hepatocellular carcinoma; Palliative radiotherapy; Primary liver cancer

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BONE METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; KLATSKIN TUMOR; LIVER CANCER; LIVER CELL CARCINOMA; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL TIME; SYMPTOM; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 83055172218     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700512     Document Type: Article

References (22)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol, 2: 533-543, 2001.
2. Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL: Extrahepatic metastases of hepatocellular carcinoma. Radiology, 216: 698-703, 2000. (Pubitemid 30660840)
3. Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K, Ikari T: Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer, 51: 863-877, 1983. (Pubitemid 13143165)
4. Primary liver cancer in Japan. The Liver Cancer Study Group of Japan. Cancer, 54: 1747-1755, 1984.
5. Fukutomi M, Yokota M, Chuman H, Harada H, Zaitsu Y, Funakoshi A, Wakasugi H, Iguchi H: Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol, 13: 1083-1088, 2001. (Pubitemid 32905203)
6. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F: Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol, 102: 1661-1670; quiz 60, 71, 2007.
7. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Hayashi K, Honda T, Kitabatake S, Kuzuya T, Nonogaki K, Kasugai T, Shimizu J: Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan. Cancer, 100: 2415-2421, 2004. (Pubitemid 38657890)
8. He J, Zeng ZC, Tang ZY, Fan J, Zhou J, Zeng MS, Wang JH, Sun J, Chen B, Yang P, Pan BS: Clinical features and prognostic factors in patients with bonemetastases fromhepatocellular carcinoma receiving external beam radiotherapy. Cancer, 115: 2710-2720, 2009.
9. Roca EL, Okazaki N, Okada S, Nose H, Aoki K, Akine Y, Egawa S: Radiotherapy for bone metastases of hepatocellular carcinoma. Jpn J Clin Oncol, 22: 113-116, 1992.
10. Murakami R, Baba Y, Furusawa M, Yokoyama T, Nishimura R, Uozumi H, Hatanaka Y, Yamashita Y, Takahashi M: Short communication: the value of embolization therapy in painful osseous metastases from hepatocellular carcinomas; comparative study with radiation therapy. Br J Radiol, 69: 1042-1044, 1996. (Pubitemid 26388611)
11. Taki Y, Yamaoka Y, Takayasu T, Ino K, Shimahara Y, Mori K, Morimoto T, Ozawa K: Bone metastases of hepatocellular carcinoma after liver resection. J Surg Oncol, 50: 12-18, 1992.
12. Kaizu T, Karasawa K, Tanaka Y, Matuda T, Kurosaki H, Tanaka S, Kumazaki T: Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients. Am J Gastroenterol, 93: 2167-2171, 1998. (Pubitemid 29076869)
13. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94: 153-156, 2001. (Pubitemid 32911406)
14. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT: NIH conference. Hepatocellular carcinoma. Ann Intern Med, 108: 390-401, 1988.
15. Chin PL, Chu DZ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD: Ethnic differences in the behavior of hepatocellular carcinoma. Cancer, 85: 1931-1936, 1999. (Pubitemid 29202766)
16. McQuay HJ, Collins SL, Carroll D, Moore RA: Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev, (2): CD001793, 2000.
17. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD: Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of randomised trials. Clin Oncol (R Coll Radiol), 15: 345-352, 2003. (Pubitemid 37069647)
18. Seong J, Koom WS, Park HC: Radiotherapy for painful bone metastases from hepatocellular carcinoma. Liver Int, 25:261-265, 2005.
19. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bonemetastases. Int J Radiat Oncol Biol Phys, 55: 594-605, 2003. (Pubitemid 36170000)
20. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M: Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst, 97:798-804, 2005.
21. Gripp S, Moeller S, Bolke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M, Willers R: Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol, 25: 3313-3320, 2007. (Pubitemid 47325618)
22. Gripp, S, Mjartan, S, Boelke, E, Willers, R: Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth? Cancer, 116: 3251-3256, 2010.